Inc. (NYSE: BIO and BIO.B), a $8.49 billion market cap company known for its life science research and clinical diagnostics products, has announced plans to acquire Stilla Technologies, a developer of ...
Laboratories “announced that the company has entered into a binding offer to purchase all equity interests in Stilla ...
Aero India 2025 showcases India's advancements in defence technology, with Zen Technologies and MKU Ltd highlighting their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback